DTIL SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0002033801-26-000004
DTIL filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 24, 2026. An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Precision Biosciences Inc (DTIL). The stock moved -4.5% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Precision Biosciences Inc (DTIL). The filing indicates a change in the holder's ownership stake.
Key details
How DTIL stock reacted
Close before
$8.85
Aug 21, 2026
First close after
-4.52%
$8.45
5 trading days
-12.09%
$7.78
Since filing
+19.77%
$10.60
✦ Ask GOAX AI about this filing — what it means for DTIL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DTIL?
Click hereFrequently asked questions
What did DTIL file with the SEC on Aug 24, 2026?
DTIL filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G regarding its beneficial ownership position in Precision Biosciences Inc (DTIL). The filing indicates a change in the holder's ownership stake.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did DTIL stock react to this filing?
DTIL closed at $8.85 before the filing and $8.45 on Aug 24, 2026 (-4.52%). Five trading days later: $7.78 (-12.09%).
Other DTIL SEC filings
- 8-K · Secondary offeringNov 6, 2026
- 424B5 · Secondary offeringNov 6, 2026
- 8-K · Fda approvalNov 5, 2026
- SCHEDULE 13G/A · SEC filingNov 3, 2026
- 8-K · SEC filingNov 3, 2026
- 10-Q · SEC filingNov 3, 2026
- SCHEDULE 13G · SEC filingOct 27, 2026
- 8-K · SEC filingAug 24, 2026
- 8-K · SEC filingAug 6, 2026
- 10-Q · SEC filingAug 6, 2026
Get alerts when DTIL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days